Updated Date: Fri, 02 May 2025 00:00:00 EDT
Updated Date: Wed, 30 Apr 2025 00:00:00 EDT
Updated Date: Wed, 30 Apr 2025 00:00:00 EDT
Teprotumumab approved as first targeted treatment for thyroid eye disease
Study explores whether PI3Kδ targeting could combat resistance
A new strategy may help prevent or slow the progression of Type 1 diabetes.
Groundbreaking device instantly detects dangerous street drugs, offering hope for harm reduction A portable device that instantly detects […]
UCB’s developmental treatment may be eligible for patient access
Demonstrate your skill and prowess by entering this year’s awards!